Trial Counsel in Oxymorphone Litigation
May 2018 and 2019
Endo and Mallinckrodt v. Amneal Pharms. LLC (D. Del.); Endo and Gruenenthal v. Amneal Pharms. LLC (S.D.N.Y.)
Robins Kaplan LLP served as lead trial counsel to Amneal in Hatch-Waxman patent litigation in the District of Delaware and the Southern District of New York brought by plaintiffs, asserting infringement of a patent claiming a form of oxymorphone. While on appeal, the FDA made Endo withdraw its oxymorphone product from the market and the case ultimately settled.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.